Genflow Biosciences Plc (WQ5) Income Statement
Genflow Biosciences Plc Income Statement
Last quarter (Q2 2026), Genflow Biosciences Plc's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Genflow Biosciences Plc's net income was $-210.12K. See Genflow Biosciences Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 169.85K | $ 0.00 | $ 0.00 | |
| $ -1.09K | $ -1.20K | $ -1.03K | $ -130.00 | $ 0.00 | |
| $ 2.00M | $ 1.91M | $ 1.80M | $ 1.33M | $ 988.10K | |
| Depreciation and Amortization | $ 1.09K | $ 1.18K | $ 1.03K | $ 129.00 | $ 0.00 |
| $ -2.00M | $ -1.59M | $ -1.80M | $ -1.33M | $ -988.10K | |
| $ -2.00M | $ -1.59M | $ -2.03M | $ -1.82M | $ -988.10K | |
| $ 585.61K | $ 320.47K | $ 169.85K | $ 486.91K | $ -99.00 | |
| $ -1.42M | $ -1.59M | $ -1.86M | $ -1.34M | $ -988.20K | |
| $ -1.42M | $ -1.59M | $ -1.63M | $ -1.34M | $ -988.29K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.00 | $ -0.00 |
| Diluted EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.00 | $ -0.00 |
| Weighted Average Shares Outstanding | 426.71M | 334.46M | 292.51M | 292.51M | 292.51M |
| Weighted Average Shares Outstanding (Diluted) | 426.71M | 334.46M | 292.51M | 292.51M | 292.51M |
Currency in GBP